Initial Notes
Note · Mirum Pharmaceuticals, Inc.
Reference: Initial Notes
- Original principal
- USD 690,000,000
- Outstanding
- —
- Commitment
- —
- Availability
- —
- Maturity
- —
Covenant terms for this agreement are not yet verified.
Documents and filing history
-
Issuance
· 2026-05-18
Original principal USD 690,000,000 Exact source document
Parent 8-K filing · 2026-05-18
(A) *Initial Notes*. On the Issue Date, there will be originally issued six hundred ninety million dollars ($690,000,000) aggregate principal amount of Notes, subject to the provisions of this Indenture (including **Section** **2.02**). Notes issued pursuant to this **Section** **2.03(A)**, and any Notes issued in exchange therefor or in substitution thereof, are referred to in this Indenture as the “**Initial Notes**.”
Issuer evidence: **INDENTURE**, dated as of May 15, 2026, between Mirum Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “**Company**”), and U.S. Bank Trust Company, National Association, as trustee (the “**Trustee**”).
Supporting evidence: (B) *Additional Notes*. Without notice to or the consent of any Holder, the Company may, subject to the provisions of this Indenture (including **Section** **2.02**), originally issue additional Notes with the same terms as the Initial Notes (except, to the extent applicable, with respect to the Last Original Issue Date of such additional Notes), which additional Notes will, subject to the foregoing, be considered to be part of the same series of, and rank equally and ratably with all other, Notes issued under this Indenture; *provided*, *however*, that if any such additional Notes (and any Notes that are resold after such Notes have been purchased or otherwise acquired by the Company or its Subsidiaries) are not fungible with other Notes issued under this Indenture for purposes of federal income tax or federal securities laws or, if applicable, the Depositary Procedures, then such additional Notes (or resold Notes) will be identified by a separate CUSIP number or by no CUSIP number.
Supporting evidence: (A) *Initial Notes*. On the Issue Date, there will be originally issued six hundred ninety million dollars ($690,000,000) aggregate principal amount of Notes, subject to the provisions of this Indenture (including **Section** **2.02**). Notes issued pursuant to this **Section** **2.03(A)**, and any Notes issued in exchange therefor or in substitution thereof, are referred to in this Indenture as the “**Initial Notes**.”